[
  {
    "chunk_id": 0,
    "start": "00:00:00.000",
    "end": "00:00:44.108",
    "audio_caption": "The audio begins with the distinct sound of squeaking, accompanied by what seems to be a hissing or pressurized release. This sound effect soon transitions into a male speaker starting with a greeting and introducing himself, indicating his intention to discuss artificial kidneys and the development of the company behind them. He emphasizes the aim of building artificial kidneys to help patients with kidney failure, characterizing the problem as a global issue. He further states that about 10% of the world population is affected by chronic kidney disease, his voice maintaining a serious tone."
  },
  {
    "chunk_id": 1,
    "start": "00:00:44.108",
    "end": "00:01:04.612",
    "audio_caption": "The clip begins with a single male speaker discussing the number of patients with end-stage renal disease and kidney failure worldwide, conveying a serious and informative tone. He emphasizes that many more patients lack access to effective treatment globally."
  },
  {
    "chunk_id": 2,
    "start": "00:01:04.612",
    "end": "00:01:38.231",
    "audio_caption": "The audio begins with a male speaker discussing access to treatment, mentioning countries like the United States, Germany, and China. His tone is informative and somewhat academic. He transitions to discussing waiting lists for organ transplants in the U.S., highlighting that the majority are waiting for kidneys."
  },
  {
    "chunk_id": 3,
    "start": "00:01:38.231",
    "end": "00:02:04.092",
    "audio_caption": "The audio clip begins with a single male speaker addressing a serious problem, citing, \"650,000 patients with kidney failure\" and \"only 20,000 kidneys available.\" He goes on to describe the long wait times and the need for dialysis. His tone is grave, emphasizing the urgency of the situation."
  },
  {
    "chunk_id": 4,
    "start": "00:02:04.092",
    "end": "00:02:17.456",
    "audio_caption": "The audio clip begins with a male speaker stating that \"dialysis costs about $82,000 per patient per year\" and explains that \"it adds up to this huge market size of more than 50 billion dollars per year in the US alone,\" spoken in a matter-of-fact tone."
  },
  {
    "chunk_id": 5,
    "start": "00:02:17.456",
    "end": "00:02:49.557",
    "audio_caption": "A male speaker explains that dialysis was invented by Dr. Kolf in 1943. He adds that the technology has changed little since then, noting its beginning with the use of sausage skin as a membrane to clean blood. He explains how the sausage skin technology has evolved into polymer membranes for blood dialysis, though he also emphasizes that the overall technology itself remains mostly unchanged. His tone is informative and explanatory."
  },
  {
    "chunk_id": 6,
    "start": "00:02:49.557",
    "end": "00:03:32.891",
    "audio_caption": "The clip begins with a male speaker describing a hypothetical scenario of being attached to a dialysis machine, detailing the time commitment and emotional distress involved. The tone is serious and empathetic, emphasizing the physical and emotional pain experienced by dialysis patients. He highlights their restricted diet and high mortality rate. The clip ends abruptly without any music or distinct background sounds."
  },
  {
    "chunk_id": 7,
    "start": "00:03:32.891",
    "end": "00:04:08.440",
    "audio_caption": "The clip starts with a male speaker discussing scientific evidence, indicating that increasing treatment frequency \"for improving survival rate of these patients\" is beneficial, even doubling it to six times a week. He mentions data collected over 12 months, demonstrating improved survival rates. There is a quiet background ambience throughout."
  },
  {
    "chunk_id": 8,
    "start": "00:04:08.440",
    "end": "00:04:15.095",
    "audio_caption": "The audio clip begins with a male speaker stating \"That's why we're building an artificial kidney as a wearable device.\""
  },
  {
    "chunk_id": 9,
    "start": "00:04:15.095",
    "end": "00:05:38.501",
    "audio_caption": "The clip begins with the speech of a male speaker introducing a miniaturized device for blood purification, explaining how it will improve patient quality of life compared to dialysis. He highlights its small size, accessibility, and user-friendliness. He describes the technology behind the device as a nanofiltration system based on kidney filtration, using a blood-friendly porous material. He mentions animal model testing at UCLA using 65-kilogram pigs."
  },
  {
    "chunk_id": 10,
    "start": "00:05:38.501",
    "end": "00:05:52.465",
    "audio_caption": "The clip begins with a male speaker advising, \"to do so, you need to first submit an application for Ethics Committee, get the approval and after that you're good to go.\" He then continues summarizing \"after completion of all that process, we went ahead with the study.\" This speech is followed by a sound that is unidentified."
  },
  {
    "chunk_id": 11,
    "start": "00:05:52.465",
    "end": "00:06:36.475",
    "audio_caption": "The audio clip starts with a male speaker describing a study in which kidneys were removed from pigs and connected to devices. He mentions that the next slide will show a short video clip from one of the experiments. He describes an operating room, device connected to a pig and that the animal is covered by a blanket. He mentions the collection of uremic toxins and fluids using their device from a living animal. The clip ends with a mechanical whirring sound."
  },
  {
    "chunk_id": 12,
    "start": "00:06:36.475",
    "end": "00:07:25.075",
    "audio_caption": "The clip begins with applause, followed by a male speaker commenting on the clapping being partial. Then, the male speaker begins a presentation about samples taken from a pig. He states that they confirmed blood flow and filtration in a device and that they were removing fluid from the body of the animal, which equates to what would be removed from a human patient every day."
  },
  {
    "chunk_id": 13,
    "start": "00:07:25.075",
    "end": "00:07:34.605",
    "audio_caption": "The audio features a single male speaker, presumably giving a presentation or announcement. He speaks in a factual tone, mentioning collaborations with several institutions like \"Stanford University, UCLA, University of California, Irvine in the US, and few hospitals in Canada\". The speaker then pauses briefly."
  },
  {
    "chunk_id": 14,
    "start": "00:07:34.605",
    "end": "00:08:08.174",
    "audio_caption": "The audio clip begins with a male speaker describing a business model, stating that their devices are provided to distribution channels and rented for 50 bucks a day. The speaker says that the distribution channel would get reimbursed from insurance companies and that they are providing the device for no cost to the patients. The speaker, in a confident tone, also mentions they expect to generate about 180 million dollars a year if they recruit 10,000 patients."
  },
  {
    "chunk_id": 15,
    "start": "00:08:08.174",
    "end": "00:08:31.873",
    "audio_caption": "A male speaker begins in a positive and informative tone, discussing collaboration with the FDA and the completion of a process for an \"expedited access program.\" He mentions completing animal studies and moving forward with clinical studies, aiming to bring a device to market in about four years."
  },
  {
    "chunk_id": 16,
    "start": "00:08:31.873",
    "end": "00:08:54.759",
    "audio_caption": "A male speaker is enthusiastically discussing media coverage and highlights one instance in particular, where their project was featured as \"one of the three ways only three ways in the world that people are making artificial kidneys.\" He also mentions that \"the other two are academic projects.\""
  },
  {
    "chunk_id": 17,
    "start": "00:08:54.759",
    "end": "00:09:20.483",
    "audio_caption": "The clip starts with a male speaker who says they are \"extremely lucky to have investors from Silicon Valley and New York Estate,\" along with support from government agencies. He sounds enthusiastic, and he invites anyone interested in helping millions of patients to talk to him after the presentation, thanking the audience. This is followed by applause."
  }
]